Developing and launching new compounded products within a 503B outsourcing environment requires careful evaluation of regulatory expectations, clinical demand, formulation feasibility, operational capability, and quality considerations. Product selection and development decisions must align with FDA guidance, cGMP requirements, stability considerations, sterility assurance expectations, and commercial scalability.

VeritasRx provides strategic and operational support throughout the product development lifecycle, including market and demand assessment, formulation and manufacturing feasibility review, regulatory risk evaluation, workflow integration, equipment and facility considerations, and implementation planning. Our team works closely with clients to help develop compliant, commercially viable, and operationally sustainable product offerings designed to support long-term growth and regulatory readiness.